Close Menu

NEW  YORK, Nov. 7 – Glycominds of Israel has raised $7.1 million in a private financing round, the company said.

The company, which is developing technologies for analyzing the interactions between complex carbohydrates, or glycans, received the funding from Israel's Millennium Materials Technologies Fund, Schott Glas, a German manufacturer of special materials, and other undisclosed venture capital funds.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.